-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Breakout 4: Developing a Palliative Care/Difficult Discussion Curriculum

Program: Special-Interest Sessions
Session: Medical Educators Symposium
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Workforce, Education
Sunday, December 8, 2024, 7:30 AM-9:30 AM

Thomas W. LeBlanc, MD, MA, MS

Duke Cancer Institute, Hillsborough, NC

Disclosures: LeBlanc: BMS/Celgene: Consultancy, Honoraria, Research Funding, Speakers Bureau; Genentech: Consultancy, Honoraria; Pfizer: Consultancy, Honoraria; Apellis: Consultancy; Astellas: Consultancy, Honoraria; Agios/Servier: Consultancy, Honoraria, Speakers Bureau; AstraZeneca: Consultancy, Honoraria; GSK: Consultancy, Honoraria, Research Funding; Menarini/Stemline: Consultancy; Novartis: Consultancy; Lilly: Consultancy, Honoraria; Gilead: Consultancy; Incyte: Honoraria, Speakers Bureau; Rigel: Consultancy, Honoraria, Speakers Bureau; Jazz Pharmaceuticals: Research Funding; AbbVie: Consultancy, Honoraria, Research Funding, Speakers Bureau; Dosentrx: Current holder of stock options in a privately-held company; ThymeCare: Current holder of stock options in a privately-held company.

See more of: Medical Educators Symposium
See more of: Special-Interest Sessions
<< Previous Presentation | Next Presentation